Our expertise helps our clients to achieve high quality results for the analysis of protein complexes, antibodies and therapeutic proteins. CovalX is offering instrumentation and analytical service worlwide to more than one hundred pharma and biotech companies. With offices and laboratories in Switzerland, France and USA, CovalX enhance and accelerate the understanding of discovery process, preclinical manufacturing process and quality issues. CovalX is a partner of choice for Pharmaceutical and Biotechnology companies for the development of their therapeutic proteins: High-resolution epitope mapping, aggregation analysis, Ab/Ag characterisation.
Location: Switzerland, Zurich
Investors 2
| Date | Name | Website |
| - | VentureLab | venturelab... |
| - | StartAngel... | startangel... |
Mentions in press and media 3
| Date | Title | Description |
| 09.02.2023 | CovalX expanding analytical services towards ICH Q6B guidelines for Biologics | ZURICH and MARTILLAC, France and SAUGUS, Mass. (PRWEB) February 09, 2023 CovalX announces the expansion of its CRO analytical capabilities to offer additional services that include analytical characterization services for investigational ne... |
| 11.03.2014 | CovalX steps into the Chinese market | |
| 10.06.2013 | CovalX and Bruker Announce Strategic Collaboration |